In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...

A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...

Smoke from wildfires — like the ones in Los Angeles — can have health consequences. Here's what experts expect.

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

While wildfires can cause immediate destruction to homes and towns, a few weeks of smoke exposure should not have long-term ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.